Smallpox vaccine, IMVANEX, to be supplied to unknown European country in response to monkeypox

NewsDesk @bactiman63 Bavarian Nordic A/S announced Thursday that the Company has secured a contract with an undisclosed European country to supply its IMVANEX(R) smallpox vaccine in response to new cases of monkeypox evolving during May 2022. Bavarian Nordic's smallpox vaccine is approved in the U.S. as JYNNEOS(R) and in Canada as IMVAMUNE(R), both places with the approval extended [...]

The post Smallpox vaccine, IMVANEX, to be supplied to unknown European country in response to monkeypox appeared first on Outbreak News Today.